Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chimerix Inc (NQ: CMRX )

1.820 -0.020 (-1.09%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 701,245
Open 1.840
Bid (Size) 1.800 (10)
Ask (Size) 1.850 (1)
Prev. Close 1.840
Today's Range 1.780 - 1.865
52wk Range 1.270 - 6.430
Shares Outstanding 86,249,744
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy. 
Via InvestorPlace
Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference
From Chimerix, Inc.
Via Globe NewsWire

Performance

YTD
-2.67%
-2.67%
1 Month
-2.67%
-2.67%
3 Month
-6.19%
-6.19%
6 Month
-22.88%
-22.88%
1 Year
-68.73%
-68.73%

More News

Read More
Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update
From Chimerix, Inc.
Via Globe NewsWire
Chimerix Responds to Rubric Capital Management
From Chimerix, Inc.
Via Globe NewsWire
Chimerix: Q2 Earnings Insights
Via Benzinga
Rubric Capital Management Sends Letter to Chimerix Board of Directors
From Rubric Capital Management LP
Via Business Wire
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
Via Benzinga
Chimerix: Q3 Earnings Insights
Via Benzinga
Why Etsy Shares Are Trading Sharply Higher; Here Are 31 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via Globe NewsWire
Chimerix's Earnings: A Preview
Via Benzinga
Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Update on November 3, 2022
From Chimerix, Inc.
Via Globe NewsWire
$1.2 Million Bet On ChromaDex? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Via Benzinga
Why Chimerix Stock Is Soaring Today
Via Benzinga
Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday
Via Benzinga
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed
Via Benzinga
Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher
Via InvestorPlace
Chimerix Earnings Preview
Via Benzinga
Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak
Via Benzinga
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
Via Benzinga
Crude Oil Drops 1%; General Motors Earnings Miss Views
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.